Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Profile: Board of Directors, Capital Structure, Raw Materials & More

Company CV

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

No Company Details Available

Shareholding

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.14%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

No Data

Stock DNA

Revenue and Profits:

Net Sales:

21,655 Million

(Quarterly Results - Jun 2026)

Net Profit:

386 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

HKD 2,929 Million ()

P/E

1.00

Industry P/E

Dividend Yield

6.07%

Debt Equity

-0.14

Return on Equity

6.63%

Price to Book

0.06